FDA Adverse Event Injury Summary report: N

DYMIC

MDR report key: 20187108 · Received September 11, 2024

Report

Report Number
3009161350-2024-71862
Event Type
Injury
Date Received
September 11, 2024
Date of Event
July 23, 2021
Report Date
September 11, 2024
Manufacturer
PALTOP ADVANCED DENTAL SOLUTIONS INC.
Product Code
DZE
UDI-DI
D76821700080
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
RS
Reporter Occupation
DENTIST
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

FAILURE TO OSSEOINTEGRATE IS A WELL-KNOWN AND INHERENT RISK OF DENTAL IMPLANTS AND IS DOCUMENTED IN THE LITERATURE ACROSS IMPLANT SYSTEMS 1, 2 (SEE E.G., KELLER, 1995; BORNSTEIN, 2008,). PALTOP DENTAL SOLUTIONS INC. PROVIDES IFU WITH ALL IMPLANTS. FAILURE TO OSSEOINTEGRATE AND LOSS OF OSSEOINTEGRATION (IMPLANT MOBILITY) IS IDENTIFIED AS AN ADVERSE REACTION AND IDENTIFIED IN THE LIST OF WARNINGS IN ALL END-OSSEOUS DENTAL IMPLANT LABELING. THE SPECIFIC CAUSE FOR A PARTICULAR COMPLAINT IS OFTEN NOT READILY IDENTIFIED AS THERE ARE VARIOUS FACTORS THAT CONTRIBUTE TO THE RISK OF IMPLANT FAILURE. THESE INCLUDE SYSTEMIC MEDICAL CONDITIONS (UNCONTROLLED DIABETES MELLITUS, AIDS, OSTEOPOROSIS), POOR BONE QUALITY AND QUANTITY OF BONE IN WHICH THE IMPLANT IS IMPLANTED, MEDICATIONS (CORTICOSTEROIDS, BISPHOSPHONATES), HARMFUL HABITS TO HEALING (SMOKING), SECONDARY INFECTION AND/OR SURGICAL TRAUMA, INEXPERIENCED CLINICIAN, IMPROPER SURGICAL TECHNIQUE, OR MOBILITY OF THE IMPLANT LEADS TO ITS REMOVAL OR REPLACEMENT, HENCE DENTAL IMPLANT FAILURE. IN ADDITION, A RATE OF IMPLANT FAILURE THAT DOES NOT AFFECT THE PRODUCTS' RISK ASSESSMENT DOES NOT REQUIRE INVESTIGATION AS IT IS A WELL-KNOWN FAILURE MODE THAT HAS BEEN ADEQUATELY STUDIED IN THE PAST.

Description of Event or Problem · 0

FAILED TO OSSEOINTEGRATE

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
538891 DYMIC DYNAMIC IMPLANT SP 4.2X11.5 DZE PALTOP ADVANCED DENTAL SOLUTIONS INC. 21-70008 WO-015426 D76821700080

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention